Back to all studies
RecruitingNCT05028738

Patient-oriented Randomized Pragmatic Feasibility Trial with RTMS in Depression and Anxiety

This recruiting study focuses on depression and currently lists sites or participation links in Canada.

DepressionOtherOver 18 Years
In plain English

Key information made simple

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits. For people living with Depression, access and fit can matter just as much as the treatment itself. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a lab, with sites including Non-Invasive Neurostimulation Therapies (NINET) Laboratory, UBC Department of Psychiatry in Vancouver. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent and meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and pregnancy or breastfeeding. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT05028738. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in Canada.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com